by rss feed | Nov 30, 2023 | Bruce Levine, CAR-T, CAR-T cells, News Feeds
The FDA issued a statement this week that there have been reports of new cases of blood cancer after patients received CAR-T therapies. The FDA specifically mentions T cell malignancies. New cancers in rare cases? In the announcement, FDA Investigating Serious Risk of...
